Achieve Clinical Research Announces Rheumatoid Arthritis Research Studies in Birmingham, Alabama

Online, September 14, 2011 (Newswire.com) - Birmingham, Alabama- Achieve Clinical Research, a privately owned research facility, founded in 1998 in Birmingham, Alabama, announces the launch of several research studies to test investigational treatment options for those already diagnosed with rheumatoid arthritis. "Through clinical research studies, we can strive to significantly build on data previously conducted on those currently diagnosed with rheumatoid arthritis," says Hayes Williams, MD, PhD., the Medical Director and Principal Investigator at Achieve Clinical Research since 2001. "Treatments for rheumatoid arthritis are one of the research studies we are pleased to continue with at Achieve Clinical Research. Our systemic evaluation clinical research trials are designed specifically to test the safety and efficacy of treatments for humans."

The research studies will enroll those already diagnosed with rheumatoid arthritis , which includes symptoms like pain or discomfort in the abdomen, drastic change in the frequency or consistency of stool, feeling of urgency, or passage of mucus. In order to participate in the studies, volunteers must already be diagnosed with rheumatoid arthritis.

Achieve Clinical Research will not take volunteers who:

have any evidence or treatment of malignancy within the previous 5 years
have a history of alcohol or substance abuse within the previous 5 years
have used an investigatory medicine or participated in an investigatory study within 30 days of the screening
are pregnant
are breast-feeding

Achieve Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. Achieve is currently enrolling people for two seperate rheumatoid arthritis studies in Birmingham, AL. One is for adults aged 18-75 and one is for seniors age 76+. For more information regarding participation in our research studies, contact Achieve Clinical Research at 205.757.8208, or at www.AchieveClinical.com.